Research use only · Not for human or veterinary consumption · Not for self-administration
B&L
BY & LARGE
PEPTIDES
Reference · November 2026
3ml research unit reference.
Research-reference tiers · U100 pen & syringe conversions
Research reference only
Research-reference tiers with arithmetic U100 conversions—not human-use or self-administration guidance.
Assumes 3ml water unless noted (5-Amino-1MQ and AICAR use 2ml; Lipo C is ready to use) and a U100 device where 1 unit = 0.01ml. Confirm reusable-pen calibration against its manual.
| ProductVial strength · water | SolutionTotal mg/ml | BeginnerResearch amount · units | IntermediateResearch amount · units | AdvancedResearch amount · units | Research-reference frequencyPer administration unless stated otherwise |
|---|---|---|---|---|---|
| Reta40mg vial | 13.33mg/ml | 2mg15 units | 4–6mg30–45 units | 8–12mg60–90 units | Once weekly, or split 2× weekly · 4-week escalation steps · any time of day |
| Reta30mg vial | 10mg/ml | 2mg20 units | 4–6mg40–60 units | 8–12mg80–120 units | Once weekly, or split 2× weekly · 4-week escalation steps · any time of day |
| Tirzepatide40mg vial | 13.33mg/ml | 2.5mg18.75 units | 5–7.5mg37.5–56.25 units | 10–15mg75–112.5 units | Once weekly, or split 2× weekly · 2.5mg steps every 4 weeks · any time of day |
| Tirzepatide30mg vial | 10mg/ml | 2.5mg25 units | 5–7.5mg50–75 units | 10–15mg100–150 units | Once weekly, or split 2× weekly · 2.5mg steps every 4 weeks · any time of day |
| Wolverine Stack20mg vial · 10mg + 10mg | 6.67mg/ml total blend | 250mcg total3.75 units | 500mcg total7.5 units | 1mg total15 units | Once daily · beginner 4 weeks; intermediate/advanced 4–6 weeks · morning. Advanced may instead use 500mcg (7.5 units) morning + evening |
| Epithalon50mg vial | 16.67mg/ml | 5mg30 units | 10mg60 units | 10mg60 units / admin | Beginner/intermediate: 1× daily, morning · advanced: 2× daily, morning + evening · 10–20 day cycles, repeated every 3–6 months |
| Eloralintide10mg vial | 3.33mg/ml | 1mg30 units | 2.5mg75 units | 5mg150 units | 1× weekly · any time of day · long-acting amylin analogue; titrate gradually |
| 5-Amino-1MQ50 vial · 2ml water | 25mg/ml | 1mg4 units | 2mg8 units | 2mg8 units / admin | 1× daily, morning (advanced 2× daily, morning + evening) · subq |
| AICAR50mg vial · 2ml water | 25mg/ml | 10mg40 units | 25mg100 units | 50mg200 units | Daily or as per protocol · subq · 200 units requires two syringe fills |
| Selank10mg vial | 3.33mg/ml | 250mcg7.5 units | 500mcg15 units | 1mg30 units | 1× daily · morning · subq or intranasal |
| Semax10mg vial | 3.33mg/ml | 200mcg6 units | 300mcg9 units | 500mcg15 units | 1–2× daily · morning + early afternoon · subq or intranasal |
| Selank + SemaxSpray kit · 20mg in 3ml | 6.67mg/ml blend | 1 spray / nostril2 sprays | 1–2 sprays / nostril2–4 sprays | 2–3 sprays / nostril4–6 sprays | Intranasal · beginner 1× daily; intermediate/advanced 2× daily, morning + early afternoon · ≈0.1ml (≈670mcg blend) per spray |
| Lipo C Fat Blaster10ml ready-to-use | No mixing300mg/ml L-carnitine | 0.5ml50 units | 1ml100 units | 1ml100 units | Beginner/intermediate 1–2× weekly · advanced 2–3× weekly · morning · subq or IM |
Split weekly: halve units per administration. Wolverine amounts are total blend; each component is half. Rounded values; powder displacement and device dead space not included.
Research & handling notes
- All products are supplied strictly for laboratory research purposes—not human or veterinary consumption, diagnosis, treatment or self-administration.
- These are research-reference tiers, not validated human dosing or By & Large recommendations.
- Units are U100 volume equivalents only. Confirm the syringe and reusable pen are calibrated to 0.01ml per unit.
- Keep unopened lyophilised vials in a cool, dark place. Once reconstituted, store in the fridge at 2–8°C and use within 2 months.
Scientific context & references
- NEJM — Retatrutide for Obesity, phase 2 trial, 2023.
- The Lancet — Eloralintide, selective amylin agonist, phase 2 trial, 2025.
- Lilly — What to know about retatrutide, reviewed September 2026.
- FDA — Mounjaro (tirzepatide) Prescribing Information.
- PubMed — Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
- PubMed — Epithalon peptide, telomerase activity and telomere elongation, 2003.
- PubMed — Overview of Epitalon, pineal tetrapeptide research.
Research use only · Not for human or veterinary consumption · Not for self-administration